Cancer Research

At Houston Methodist, our dedicated teams of world-renowned researchers help support the mission of our oncologists of bringing the latest technologies and advanced treatment options to patients as quickly and safely as possible. Our researchers conduct translational research and support numerous cancer-specific clinical trial protocols for brain, breast, liver, lung and many other forms of cancer.

Clinical and translational research plays a vital role in determining treatment plans at Houston Methodist and in bringing tomorrow's cures to our patients today. Explore the bridges between research and clinical care that have been built by our interdisciplinary faculty team and global network of collaborators.

SCIENTISTS DETECT NEW OVARIAN CANCER TARGET, FIND EXISTING DRUG TO POTENTIALLY TREAT IT

Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center found that a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. Learn more.

Houston Methodist Expands Cancer Biology, Surgical Oncology, and Cancer Prevention & Control Programs

Houston Methodist expanded its basic cancer research program, cancer prevention and control efforts, and surgical oncology services with the addition of Qing Yi, MD, PhD, and Nestor Esnaola, MD, MPH, MBA. Learn more.


DOD AWARDS $4 MILLION TO COMBAT LETHAL BREAST CANCER

The DoD has awarded Rongfu Wang, PhD, and Jenny C. Chang, MD, nearly $4 million to develop a personalized immunotherapy approach to combat triple negative breast cancer. Learn more.

Jenny C. Chang, MD

Jenny C. Chang, MD, is the Emily Herrmann Chair in Cancer Research, Director of the Cancer Center, and Professor of Cancer at Houston Methodist. Learn More.